Navigation Links
Luminex and Partners HealthCare Announce Collaboration Agreement
Date:2/15/2011

AUSTIN, Texas, Feb. 15, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.  This program will enable Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to develop novel molecular diagnostic assays based on biomarkers discovered within Partners HealthCare entities.  These innovative tests will operate on Luminex's proprietary xMAP® testing platform.  Under the terms of the agreement, Luminex and PCPGM will evaluate opportunities for novel assays which will be developed and validated in the PCPGM's CLIA-certified Laboratory for Molecular Medicine.

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

"The collaboration with Luminex represents an important step forward in furthering Partners HealthCare Center for Personalized Genetic Medicine's mission to bridge the gap between research and clinical medicine," said Dr. Heidi Rehm, Director of PCPGM's Laboratory for Molecular Medicine at Partners HealthCare.  "Luminex's xMAP technology provides an ideal platform for Partners HealthCare to translate novel biomarker discoveries into cutting-edge tests and accelerate adoption of new molecular tests to provide the best clinical care for patients."  

The strength of the relationship between Luminex and PCPGM is the resources, technologies and industry experience that each organization offers, from research, development and the ability to commercialize novel molecular diagnostic assays. By utilizing Luminex's xMAP technology, PCPGM can develop novel assays and bring them from discovery to clinical diagnostics more efficiently and cost-effectively.

"Luminex and Partners HealthCare have a shared commitment to leverage genetic testing and personalized medicine to improve the quality of care and treatment for patients," said Patrick J. Balthrop, president and CEO of Luminex.  "Partners HealthCare is a premier institution with a history of proven success in the field of molecular diagnostics, and through the Center of Excellence agreement, we are confident that our joint efforts will drive market innovation and important technology advancements that will help dramatically improve patients' lives in the years ahead."

About Partners HealthCarePartners HealthCare is an integrated health system founded by Brigham and Women’s Hospital and Massachusetts General Hospital. In addition to its two academic medical centers, the Partners system includes community and specialty hospitals, community health centers, a physician network, home health and long-term care services, and other health-related entities. Partners is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School.  Partners HealthCare is a non-profit organization.

About Luminex CorporationLuminex Corporation develops, manufactures, and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate, and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics, and biomedical research, including the genomics and proteomics markets. The company's xMAP Technology is sold worldwide and is already in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, and biotechnology companies. Further information on Luminex Corporation or xMAP Technology can be obtained at www.luminexcorp.com.Contacts:Partners HealthCare:Richard W. Copp, Jr., 617.278.1031Director of Communicationsrcopp@partners.orgLuminex Investor Contact:Matthew Scalo, 512.219.8020  Sr. Director Investor Relations  mscalo@luminexcorp.comLuminex Media Contact: Mimi Torrington, 512.219.8020Director of Marketing Communicationsmtorrington@luminexcorp.comAaron DeLucia, 512.241.2249  aaron.delucia@porternovelli.com
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results
2. Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011
3. Luminex Corporation to Present at JP Morgan Healthcare Conference
4. Luminex and One Lambda Renew Long-Term Strategic Partnership
5. Luminex Corporation Board of Directors Authorizes Share Repurchase Plan Through November 2011
6. Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test
7. Luminex Corporation to Present at Stephens Fall Investment Conference
8. Luminex Corporation Reports Third Quarter 2010 Results
9. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
10. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
11. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016  Maxor National Pharmacy Services, ... of Pharmaceutical Specialties, Inc. ("PSI").  The combination of ... Georgia -based PSI bring together both company,s clinical ... manufacturers, and payers an industry-leading specialty pharmacy. About ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global law ... 21st Drug & Medical Device Litigation Conference , taking place in New York Dec. ... chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with ... that works for them. When an inventor from Suisun City, Calif., was unsuccessful in ... share it with others. , He developed a prototype for PRO GO MASSAGE to ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):